4/A
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-057531
Principal Accounting Officer sold 307 shares at $8.87 ($2,723)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PISKEL KYLE Principal Accounting Officer | 2022-11-16 | Sale | −307 | $8.87 | $2,723 | 47,358 | D: show line 1 in the form |
| Open-market sales · 307 sh · avg $8.87 · $2,723 | |||||||
Loading xslF345X03/doc4a.xml…